Phase I Clinical Trial to Evaluate the Efficacy of Sulforaphane as an Antagonist to Human PXR-Mediated Drug-Drug Interactions.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rifampicin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 06 Sep 2019 Biomarkers information updated
- 18 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Sep 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.